Feasibility and pharmacokinetics of nebulized S-ketamine inhalation in healthy adults

Feasibility and pharmacokinetics of nebulized S-ketamine inhalation in healthy adults - NebuKET

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42367

Enrollment

Registered

2015-06-25

Start date

2015-08-17

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain pain pharmacokinetics

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects of either sex (10 men/10 women), aged 18-39 years with a body mass index

Exclusion criteria

Exclusion criteria: Severe medical disease including pulmonary disease, hypertension, liver/renal disease, neurological disorders, diaphragmatic hernia/pyrosis; (history of) psychiatric or neurological disease; pregnancy/lactation; allergy to study medication; (history of) illicit drug use/alcoholism; concurrent participation in another trial.

Design outcomes

Primary

Measure	Time frame
Safety Pharmacokinetics	—

Secondary

Measure	Time frame
Pain relief	—

Countries

Netherlands

Outcome results